Spironolactone management of resistant hypertension. - Wikidata - awgldk - TriplyDB

Spironolactone management of resistant hypertension.

Spironolactone management of resistant hypertension.

http://www.wikidata.org/entity/Q37803301

about

Mineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines!Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative.Effects of spironolactone on cerebral vessel structure in rats with sustained hypertension.Evaluation and pharmacologic approach to patients with resistant hypertension.Expanding role of mineralocorticoid receptor antagonists in the treatment of heart failure.Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial.Commentary in support of a highly effective hypertension treatment algorithm.Effect of amiloride and spironolactone on renal tubular function, ambulatory blood pressure, and pulse wave velocity in healthy participants in a double-blinded, randomized, placebo-controlled, crossover trial.Serum potassium levels predict blood pressure response to aldosterone antagonists in resistant hypertension

P2860

Q26776149-1CBDB4B2-79C6-43DD-8120-400065357C7B Q36420940-2E4D2B81-E62A-45DF-B2D6-7722B6CABF9C Q36999573-2A6FF85F-865C-4820-99C5-E0175916521E Q37982211-73EE2A4F-A21C-4F37-9E95-10CC4E78AA4A Q38040730-F86A1978-8AAF-48F5-87D6-0F11FB9CDF5F Q44500956-77867B70-3425-4AD8-9FD2-E804902CE8A0 Q51136685-CF8485B6-29AC-47B2-966B-F905DF01026B Q51367511-7E67BE5C-8435-42B4-A0C6-F0D7D1B596B0 Q58855232-D94F0CA2-8ECC-4D1E-819B-24795908AE0A

P2860

Spironolactone management of resistant hypertension.

http://www.wikidata.org/entity/Q37803301

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 October 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Spironolactone management of resistant hypertension.

@en

Spironolactone management of resistant hypertension.

@nl

type

label

Spironolactone management of resistant hypertension.

@en

Spironolactone management of resistant hypertension.

@nl

prefLabel

Spironolactone management of resistant hypertension.

@en

Spironolactone management of resistant hypertension.

@nl

P1433

Q37803301-E4B3DA39-3C8B-4EBE-868A-8F758C597212

P1476

Q37803301-5B24A804-512C-40B1-B6D5-B59B4E2CABB6

P2093

Q37803301-CA43A552-D33D-48DB-B34D-6ECB5FF2EA97

P2860

Q37803301-09626EDC-229C-44F3-A4D1-8F32ECF985D2

Q37803301-0AAA6285-7739-41D9-922B-B71A4F440685

Q37803301-0F38AE27-B57D-4720-8460-D1110261E60D

Q37803301-1D8644FD-05CE-4954-BB68-A7B25672937E

Q37803301-3BF9D83B-80B0-4F66-84DE-BAC4EB2C83F5

Q37803301-53F636B0-FC64-4767-855E-C3FA4560B534

Q37803301-57287751-ED8C-4647-8E39-E72C23D23545

Q37803301-70F664FB-2CCA-4878-A57D-AAACB3613306

Q37803301-7B707523-066F-426E-9AB1-EDA2A10DB64C

Q37803301-7C4A5CA6-A7C8-45F0-85CD-69AA253835CF

P304

Q37803301-4CA08932-371C-4545-9FAA-6FAC12C5AAC6

P31

Q37803301-C7E246C7-A800-4730-9502-F3D2E074416B

P356

Q37803301-EC8F4211-4D89-4812-B47B-398FBE645A3D

P407

Q37803301-55D5CB22-85CF-49EC-9DA8-DDFC4AD0FB87

P433

Q37803301-66ED6F54-B513-4228-909A-B50B161A8EF2

P478

Q37803301-F2194D97-A1FC-4CAA-98A9-000BAAFFC44C

P577

Q37803301-BE1C37DE-5693-43DA-8B7A-6A15C1E4F4A2

P698

Q37803301-0F63F3E0-FFF0-4394-A13E-CD59239465C1

P921

Q37803301-B3C77C66-06E0-47D8-8F6B-9C563AF3FB61

P356

P1433

Annals of Pharmacotherapy

P1476

Spironolactone management of resistant hypertension.

@en

P2093

Joel C Marrs

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

Aldosterone receptor antagonists: effective but often forgotten.

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

Pharmacokinetics and pharmacodynamics of mineralocorticoid blocking agents and their effects on potassium homeostasis.

Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Aldosterone-receptor antagonism in hypertension.

Renal complications of nonsteroidal anti-inflammatory drugs.

Clinical relevance of drug interactions with lithium.

Aldosterone escape during ACE inhibitor therapy in chronic heart failure.

P304

1762-1769

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1P338

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20978214

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension